TAK-669-4018: A Survey Among Patients, Caregivers and Home Infusion Nurses Based in the European Union to Assess Their Awareness and Understanding of Educational Materials Supporting VPRIV® Infusion at Home

Study identification

• EU PAS number:
  EUPAS49598
• Study ID:
  49599
• Official title and acronym:
  TAK-669-4018: A Survey Among Patients, Caregivers and Home Infusion Nurses Based in the European Union to Assess Their Awareness and Understanding of Educational Materials Supporting VPRIV® Infusion at Home
• DARWIN EU® study:
  No
• Study countries:
  Austria

  Belgium

  Denmark

  Finland

  France

  Germany

  Ireland

  Italy

  Netherlands

  Spain
• Study description:
  The main purpose of this survey is to determine participants’, caregivers’, and nurses’ understanding and use of educational material (EM) on VPRIV home treatment. EM includes an infusion diary and guide and an emergency plan related to VPRIV infusion given at home for Gaucher disease. The survey is conducted in European countries. Data will be collected directly from participants, caregivers, and nurses in form of a questionnaire, electronic or paper.
• Study status:
  Planned

Research institutions and networks

Institutions

Takeda

Study timelines

Date when funding contract was signed

Planned: 01/12/2022

Study start date

Planned: 30/09/2026

Date of final study report

Planned: 30/09/2027

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Takeda

Regulatory

• Was the study required by a regulatory body?:
  Yes
• Is the study required by a Risk Management Plan (RMP)?:
  EU RMP category 3 (required)